Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on perampanel in benzodiazepine-resistant focal motor status epilepticus
2019-000882-19Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in focal motor status epilepticus comparing Perampanel add-on with Placebo add-on (2 arms). Primary endpoint: Seizure cessation between H2 and H3. Started Aug 2019; status: terminated.
02
Drugs
perampanel
03
Conditions
focal motor status epilepticus
Beyond the preview
Go deeper on 2019-000882-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000882-19.